未登录

E

Emmanuelle Boutmy

pfizer usa

H指数:11

被引数:498

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Incorporating estimands into meta-analyses of clinical trials

将目标参数纳入临床试验的meta分析

Research Synthesis Methods

IF6.1

2026-09-260

OA

Patients With Advanced Non–small Cell Lung Cancer Harboring MET Alterations: A Descriptive Cohort Study

携带MET变异的晚期非小细胞肺癌患者：一项描述性队列研究

Clinical Lung Cancer

IF3.3

2025-02-010

OAAI

First-line treatment (tx) patterns and overall survival (OS) of patients (pts) with advanced Merkel cell carcinoma (aMCC) in England from 2013-2022: Results of a nationwide observational cohort study

ANNALS OF ONCOLOGY

IF65.4

2023-10-011

PRE

Clinical characteristics and survival of patients with advanced Merkel cell carcinoma (MCC) treated with avelumab: Analysis of a prospective German MCC registry (MCC TRIM)

ANNALS OF ONCOLOGY

IF65.4

2023-10-011

PRE

Metformin in pregnancy and risk of abnormal growth outcomes at birth: a register-based cohort study

妊娠二甲双胍与出生时异常生长结局的风险: 一项基于登记的队列研究

BMJ OPEN DIABETES RESEARCH & CARE

IF4.1

2022-12-024

OAAI

Treatment effectiveness in a rare oncology indication: Lessons from an external control cohort study

CTS-CLINICAL AND TRANSLATIONAL SCIENCE

IF2.8

2022-06-116

OA

Identifying Valid Algorithms for Number of Lines of Anti-Neoplastic Therapy in the Danish National Patient Registry Among Patients with Advanced Ovarian, Gastric, Renal Cell, Urothelial, and Non-Small Cell Lung Cancer Attending a Danish University Hospital

clinical epidemiology

IF3.2

2022-02-012

OAAI

Metformin in pregnancy and risk of adverse long-term outcomes: a register-based cohort study

妊娠二甲双胍与不良长期结局的风险: 一项基于登记的队列研究

BMJ OPEN DIABETES RESEARCH & CARE

IF4.1

2022-01-0542

OAAI

Treatment and Survival in Advanced Non-Small Cell Lung Cancer, Urothelial, Ovarian, Gastric and Kidney Cancer: A Nationwide Comprehensive Evaluation

clinical epidemiology

IF3.2

2021-09-011

OAAI

Comparative effectiveness of recombinant human follicle-stimulating hormone alfa (r-hFSH-alfa) versus highly purified urinary human menopausal gonadotropin (hMG HP) in assisted reproductive technology (ART) treatments: a non-interventional study in Germany

重组人促卵泡激素 (r-hfsh-alfa) 与高纯度尿人绝经期促性腺激素 (hMG HP) 在辅助生殖技术 (ART) 治疗中的比较有效性: 德国的一项非干预性研究

REPRODUCTIVE BIOLOGY AND ENDOCRINOLOGY

IF4.7

2021-06-1610

OAAI

Real-world insights into patients (pts) with advanced NSCLC and MET alterations

ANNALS OF ONCOLOGY

IF65.4

2020-11-011

OAAI

DIRECT HEALTHCARE COSTS BY TREATMENT AMONG PATIENTS WITH MERKEL CELL CARCINOMA (MCC) IN THE UNITED STATES

VALUE IN HEALTH

IF6

2018-10-011

OAAI

TREATMENT PATTERNS, HEALTHCARE RESOURCE UTILIZATION AND ASSOCIATED COSTS BY LINE OF THERAPY IN NEWLY DIAGNOSED MERKEL CELL CANCER PATIENTS IN THE UNITED STATES

VALUE IN HEALTH

IF6

2018-05-011

OAAI

Differential Perceptions of Noninvasive Ventilation in Intensive Care among Medical Caregivers, Patients, and Their Relatives A Multicenter Prospective Study-The PARVENIR Study

IF9.1

2016-06-0116

PREAI

A CROSS-SECTIONAL STUDY ON INSULIN TREATMENTS AND GLYCEMIC CONTROL IN TYPE 2 DIABETES IN FRANCE, ITALY, GERMANY, UK AND SPAIN

VALUE IN HEALTH

IF6

2015-11-011

OAAI

USE OF A FRENCH CLAIMS DATABASE TO ESTIMATE REAL-WORLD TREATMENT COSTS OF BENIGN PROSTATIC HYPERPLASIA

VALUE IN HEALTH

IF6

2015-05-010

OAAI

Natural history of allergic sensitization in infants with early-onset atopic dermatitis: results from ORCA Study

PEDIATRIC ALLERGY AND IMMUNOLOGY

IF4.5

2014-11-2031

OAAI

TREATMENT MAINTENANCE DURATION OF DUAL THERAPY WITH METFORMIN AND SITAGLIPTIN IN TYPE 2 DIABETES - REAL-WORLD DATA FROM ODYSSEE STUDY

VALUE IN HEALTH

IF6

2014-11-011

OAAI

UNDERSTANDING REAL LIFE TREATMENT PATTERNS AMONG PATIENTS WITH HYPERTENSION: A MARKOV MODEL

VALUE IN HEALTH

IF6

2014-11-010

OAAI

Intensive care unit admission in chronic obstructive pulmonary disease: patient information and the physician's decision-making process

IF9.3

2014-06-0418

OAAI